Cargando…
Metastatic cardiac tumors: from clinical presentation through diagnosis to treatment
BACKGROUND: To evaluate the prevalence of metastatic tumors involving the myocardium and study their presentation in order to increase awareness to their existence. METHODS: Pathological reports from Sheba Medical Center (Israel, January 1, 2010 through December 31, 2015) and medical records from Th...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819646/ https://www.ncbi.nlm.nih.gov/pubmed/29463229 http://dx.doi.org/10.1186/s12885-018-4070-x |
_version_ | 1783301242118733824 |
---|---|
author | Burazor, Ivana Aviel-Ronen, Sarit Imazio, Massimo Goitein, Orly Perelman, Marina Shelestovich, Natalia Radovanovic, Ninoslav Kanjuh, Vladimir Barshack, Iris Adler, Yehuda |
author_facet | Burazor, Ivana Aviel-Ronen, Sarit Imazio, Massimo Goitein, Orly Perelman, Marina Shelestovich, Natalia Radovanovic, Ninoslav Kanjuh, Vladimir Barshack, Iris Adler, Yehuda |
author_sort | Burazor, Ivana |
collection | PubMed |
description | BACKGROUND: To evaluate the prevalence of metastatic tumors involving the myocardium and study their presentation in order to increase awareness to their existence. METHODS: Pathological reports from Sheba Medical Center (Israel, January 1, 2010 through December 31, 2015) and medical records from The Institute for Cardiovascular Diseases of Vojvodina, Sremska Kamenica (Serbia, 23 years period) were screened for cases of metastatic cardiac tumors. Medical, radiological and pathological data of identified cases was retrieved and reviewed. RESULTS: Out of thousands of registered cardiac surgeries we found less than a dozen cases of metastatic cardiac tumors classified as melanoma, carcinomas of lung, colon and kidney and sarcomas of uterine origin. We found that metastatic cardiac tumors comprised 15.8% of all the cardiac tumors. CONCLUSIONS: Metastatic cardiac tumors are extremely rare. As new diagnostic technologies and improved survival of oncological patients may increase the incidence of metastatic cardiac tumors in the future, awareness to their existence and knowledge of their presentation are key factors in their timely recognition. |
format | Online Article Text |
id | pubmed-5819646 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-58196462018-02-26 Metastatic cardiac tumors: from clinical presentation through diagnosis to treatment Burazor, Ivana Aviel-Ronen, Sarit Imazio, Massimo Goitein, Orly Perelman, Marina Shelestovich, Natalia Radovanovic, Ninoslav Kanjuh, Vladimir Barshack, Iris Adler, Yehuda BMC Cancer Research Article BACKGROUND: To evaluate the prevalence of metastatic tumors involving the myocardium and study their presentation in order to increase awareness to their existence. METHODS: Pathological reports from Sheba Medical Center (Israel, January 1, 2010 through December 31, 2015) and medical records from The Institute for Cardiovascular Diseases of Vojvodina, Sremska Kamenica (Serbia, 23 years period) were screened for cases of metastatic cardiac tumors. Medical, radiological and pathological data of identified cases was retrieved and reviewed. RESULTS: Out of thousands of registered cardiac surgeries we found less than a dozen cases of metastatic cardiac tumors classified as melanoma, carcinomas of lung, colon and kidney and sarcomas of uterine origin. We found that metastatic cardiac tumors comprised 15.8% of all the cardiac tumors. CONCLUSIONS: Metastatic cardiac tumors are extremely rare. As new diagnostic technologies and improved survival of oncological patients may increase the incidence of metastatic cardiac tumors in the future, awareness to their existence and knowledge of their presentation are key factors in their timely recognition. BioMed Central 2018-02-20 /pmc/articles/PMC5819646/ /pubmed/29463229 http://dx.doi.org/10.1186/s12885-018-4070-x Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Burazor, Ivana Aviel-Ronen, Sarit Imazio, Massimo Goitein, Orly Perelman, Marina Shelestovich, Natalia Radovanovic, Ninoslav Kanjuh, Vladimir Barshack, Iris Adler, Yehuda Metastatic cardiac tumors: from clinical presentation through diagnosis to treatment |
title | Metastatic cardiac tumors: from clinical presentation through diagnosis to treatment |
title_full | Metastatic cardiac tumors: from clinical presentation through diagnosis to treatment |
title_fullStr | Metastatic cardiac tumors: from clinical presentation through diagnosis to treatment |
title_full_unstemmed | Metastatic cardiac tumors: from clinical presentation through diagnosis to treatment |
title_short | Metastatic cardiac tumors: from clinical presentation through diagnosis to treatment |
title_sort | metastatic cardiac tumors: from clinical presentation through diagnosis to treatment |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819646/ https://www.ncbi.nlm.nih.gov/pubmed/29463229 http://dx.doi.org/10.1186/s12885-018-4070-x |
work_keys_str_mv | AT burazorivana metastaticcardiactumorsfromclinicalpresentationthroughdiagnosistotreatment AT avielronensarit metastaticcardiactumorsfromclinicalpresentationthroughdiagnosistotreatment AT imaziomassimo metastaticcardiactumorsfromclinicalpresentationthroughdiagnosistotreatment AT goiteinorly metastaticcardiactumorsfromclinicalpresentationthroughdiagnosistotreatment AT perelmanmarina metastaticcardiactumorsfromclinicalpresentationthroughdiagnosistotreatment AT shelestovichnatalia metastaticcardiactumorsfromclinicalpresentationthroughdiagnosistotreatment AT radovanovicninoslav metastaticcardiactumorsfromclinicalpresentationthroughdiagnosistotreatment AT kanjuhvladimir metastaticcardiactumorsfromclinicalpresentationthroughdiagnosistotreatment AT barshackiris metastaticcardiactumorsfromclinicalpresentationthroughdiagnosistotreatment AT adleryehuda metastaticcardiactumorsfromclinicalpresentationthroughdiagnosistotreatment |